🟢 EIQ.XA is trading 42.2% up today after senior U.S.-focused leadership appointments

EIQ.XA is trading 42.2% up today at A$1.76 following the appointment of new CFO Matthew Dodds and a senior clinical leader to accelerate the company's U.S. expansion strategy.

• The leadership additions are intended to drive growth in the U.S. healthcare market and advance the commercialization of AI cardiology applications.
• Investor enthusiasm is further supported by a recent research collaboration with the Mayo Clinic focused on AI-driven cardiac risk assessment.